Navigation Links
ProAssurance Reports Year-End and Fourth Quarter 2009 Results
Date:2/24/2010

future events and highlight certain risks and uncertainties that could cause actual results to vary materially from our expected results. We expressly claim the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, for any forward-looking statements in this news release.

Forward-looking statements represent our outlook only as of the date of this news release. Except as required by law or regulation, we do not undertake and specifically decline any obligation to publicly release the result of any revisions that may be made to any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

Forward-looking statements are generally identified by words such as, but not limited to, "anticipate," "believe," "estimate," "expect," "hope," "hopeful," "intend," "may," "optimistic," "potential," "preliminary," "project," "should," "will," and other analogous expressions. When we address topics such as liquidity and capital requirements, the value of our
'/>"/>

SOURCE ProAssurance
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. ProAssurance Reports Third Quarter 2009 Results
2. ProAssurance Reports Second Quarter 2009 Results
3. A. M. Best Upgrades ProAssurance Group to A (Excellent)
4. ProAssurance Closes PICA Transaction
5. PICA Policyholders Approve ProAssurance Transaction
6. Fitch Affirms ProAssurances Rating and Stable Outlook
7. ProAssurance Receives Regulatory Approvals for Transactions with the PICA Group and Georgia Lawyers Insurance Company
8. ProAssurance Acquires Mid-Continent General Agency to Expand Ancillary Healthcare Insurance Business
9. ProAssurance to Present at Oppenheimer Investor Conference
10. The PICA Group Will Become Part of ProAssurance
11. ProAssurance Group Offers Coverage for Community Based Hospitals in Michigan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Nashville, Tenn. (PRWEB) , ... July 28, 2015 ... ... has added the SmileCareClub Invisible Aligner System to its online product ... , By using a teledentistry model and cloud-based technology, SmileCareClub allows patients to ...
(Date:7/28/2015)... Wayne, PA (PRWEB) , ... July 28, 2015 ... ... that its Board of Directors has authorized the Company, from time to time ... with an aggregate value of up to $25 million. Repurchases will be made ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... services to include a proprietary, web based clinical knowledge system, called “Referral Guidance.” ... evidence based. It provides physicians who are anticipating making a subspecialty referral ...
(Date:7/28/2015)... ... 2015 , ... Fertility specialist Dr. Lisa Hasty of Atlanta Center ... Magazine. In Atlanta Magazine's annual Top Doctors issue, Dr. Hasty has been recognized for ... in the metro area as one of the most respected doctors in Reproductive Endocrinology. ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new study published ... Fibromyalgia, Study Says " sheds light on a possible new treatment option for people ... months of regular HBOT sessions, at least five per week, patients experienced a significant ...
Breaking Medicine News(10 mins):Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 2Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 3Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 2Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 3Health News:Introducing Care to Care’s New Web Based “Referral Guidance” Program 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 2Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 3
... , , Covers Europe, Middle East and ... , Includes Licensing Option and Development Funding for NGX-1998 ... June 22 NeurogesX, Inc. (Nasdaq: NGSX ) and Astellas ... Inc. announced today that the companies have entered into an exclusive Distribution, ...
... 22 Bringing the next level of technology ... eClinical solutions provider and subsidiary of PAREXEL International ... that it has launched its industry-leading eClinical Suite ... data across multiple technologies throughout the trial process. ...
... ... released by Esco. The videos can be viewed at: http://us.escoglobal.com/resources/hospital-pharmacy-products/videos.php . , ... Hatboro, PA (PRWEB) June ... and education videos for the compounding pharmacy industry. Titled "Pharmacy Isolator Safe ...
... To ... and Helen Sher, Founder of The Sher System, a drug-free therapy that has revolutionised the ... , ... -- Rosacea is a common skin condition that causes redness and swelling on the face. ...
... People with schizophrenia die from cancer four times as often ... of a new study published in the August 1, 2009 ... American Cancer Society. The study,s results suggest that extra efforts ... in patients with schizophrenia. Schizophrenia is associated with an ...
... recipients to suppress their immune systems, has a paradoxical effect ... Vaccine Center have discovered. In experiments conducted in both ... CD8 T cells, which enable the immune system to respond ... encounter. The results were published online ahead of print ...
Cached Medicine News:Health News:NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM) 2Health News:NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM) 3Health News:NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM) 4Health News:NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM) 5Health News:NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM) 6Health News:Perceptive Informatics Launches the Next Level of Integration in its Industry-Leading eClinical Suite 2Health News:Perceptive Informatics Launches the Next Level of Integration in its Industry-Leading eClinical Suite 3Health News:Perceptive Informatics Launches the Next Level of Integration in its Industry-Leading eClinical Suite 4Health News:Perceptive Informatics Launches the Next Level of Integration in its Industry-Leading eClinical Suite 5Health News:New Compounding Pharmacy Videos Provide Product Information, Teach Safety 2Health News:New Compounding Pharmacy Videos Provide Product Information, Teach Safety 3Health News:Helen Sher Launches Her Rosacea Awareness Campaign 2009 to Help Sufferers of this Distressing Condition 2Health News:Study finds cancer is the second most frequent cause of death in individuals with schizophrenia 2Health News:Transplant drug stimulates immune memory 2
(Date:7/28/2015)... Mike Rowe , spokesperson and reality television ... Pharmacy,s 2015 ThoughtSpot conference and tradeshow, which ... Las Vegas, Nev. Best known ... and Discovery Channel,s, "Dirty Jobs," Mr. Rowe spent a decade ... – people whose hard work, sacrifice and value aren,t always ...
(Date:7/28/2015)...  CryoLife, Inc. (NYSE: CRY ), a leading ... and vascular surgery, announced today its results for the ... Pat Mackin, Chairman, President and Chief Executive ... on our growth strategy with solid progress on several ... plans to transition to a direct sales model in ...
(Date:7/28/2015)... YORK , July 28, 2015 ... late-stage pharmaceutical company focused on the development and ... that new Locilex® microbiology data will be presented ... of Antimicrobial Agents and Chemotherapy and International Society ... (ICAAC/ICC 2015) scientific meeting in San ...
Breaking Medicine Technology:Mike Rowe to Address Community Pharmacists at ThoughtSpot 2015 2CryoLife Reports Second Quarter Financial Results 2CryoLife Reports Second Quarter Financial Results 3CryoLife Reports Second Quarter Financial Results 4CryoLife Reports Second Quarter Financial Results 5CryoLife Reports Second Quarter Financial Results 6CryoLife Reports Second Quarter Financial Results 7CryoLife Reports Second Quarter Financial Results 8CryoLife Reports Second Quarter Financial Results 9CryoLife Reports Second Quarter Financial Results 10CryoLife Reports Second Quarter Financial Results 11CryoLife Reports Second Quarter Financial Results 12CryoLife Reports Second Quarter Financial Results 13CryoLife Reports Second Quarter Financial Results 14Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 2Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 3
... A study comparing,the formulations of isosorbide dinitrate (ISDN) ... II, and BiDil, the proprietary,fixed dose combination, used ... no bioequivalence. Non-bioequivalence,in the formulations used may explain ... results in decreasing mortality. Using,identical amounts of active ...
... 26, 2007 /PRNewswire/ -- DiObex,Inc., a privately- ... therapeutics to treat metabolic diseases, today,announced positive ... novel Cortisol,Synthesis Inhibitor. , In a recently ... 2 diabetes were,treated for two weeks to ...
Cached Medicine Technology:Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 2Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 3Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 4Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 5Diobex Announces Successful Completion of Phase 2a Trial Of,DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes 2Diobex Announces Successful Completion of Phase 2a Trial Of,DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes 3
... , The new Finnpipette Novus is so user-friendly that ... few minutes. With the intuitive instantly familiar menu and ... functions you need quickly and easily. The large, clear ... names of all functions. The easily accessible two ...
... Transfer an Entire Column of a 384 ... and throughput with 384 well plates, you need ... well spacing. Thats exactly what you get with ... Impact2 software (see Impact/Impact2), this innovation was specifically ...
... The Seal-Away CS and Alliance ... designed for the introduction of ... coronary sinus from a superior ... Jude Medical's outstanding peel-away introducer ...
This unique hemostatic seal provides a simple option for beating heart CABG anastomoses, allowing you to use your own hand-suturing technique without the release of cerebral emboli associated with th...
Medicine Products: